Skip to content

Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids

Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01529281
Enrollment
12
Registered
2012-02-08
Start date
2011-06-30
Completion date
2011-09-30
Last updated
2012-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced Muscle Damage

Brief summary

It is well documented that exercise-induced muscle damage (EIMD) decreases muscle function and causes severe soreness and discomfort. Branched-chain amino acid (BCAA) supplementation has been shown to increase protein synthesis and decrease muscle protein breakdown, however, the effects of BCAAs on recovery from EIMD are unknown. Thus, the aim of this study was to examine the effects of a BCAA supplement on markers of muscle damage.

Interventions

DIETARY_SUPPLEMENTBranch Chain Amino Acid (BCAA)

Supplementation lasted for a total of 12 days; this was based on previous research showing a positive with BCAA supplementation on markers of muscle damage. Participants ingested 10 g, twice per day (morning and evening) of BCAA . The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The BCAA was in powder form where each serving was mixed with \ 300 ml of water.

DIETARY_SUPPLEMENTPlacebo - asparmate

Supplementation lasted for a total of 12 days. Participants ingested an equivalent looking volume to 10 g of BCAA, twice per day (morning and evening) of placebo (aspartame based artificial sweetener). The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The artificial sweetener was in powder form where each serving was mixed with \ 300 ml of water.

Sponsors

Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

\- Resistance trained males

Exclusion criteria

\- Muscular skeletal disorders

Design outcomes

Primary

MeasureTime frameDescription
Maximal voluntary contractionpre exercise, 24 h, 48 h, 72 h, 96 h post-exerciseIsometric MVC of the participants' dominant knee extensors was assessed using a strain gauge. MVCs were performed for 3 s with a 60 s rest between each repetition.

Secondary

MeasureTime frameDescription
Limb girthspre-exercise, 24h, 48h, 72h, 96hMid-thigh and calf circumference was assessed as a measure of limb swelling using an anthropometric tape measure. Both measures were obtained with the participant in a standing position.
Vertical jumppre-exercise, 24h, 48h, 72h, 96hVertical jump (VJ) performance was assessed using the Vertec instrument. Participants performed a counter movement jump.
Creatine kinasepre-exercise, 24h, 48h, 72h, 96hPlasma CK was determined from an earlobe capillary blood sample. The sample (30 microlitres) was analysed immediately using an automated, dry slide photospectrometer.
Muscle sorenesspre-exercise, 24h, 48h, 72h, 96hMuscle soreness - Participants were asked to perform and hold a squat (90° knee angle) whilst they rated their perceived muscle soreness on a 200 mm visual analogue scale. The scale consisted of a line from 0 mm (no pain) to 200 mm (unbearably painful).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026